Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001104659-23-107706
Filing Date
2023-10-10
Accepted
2023-10-10 06:01:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC14D9C tm2328024d1_sc14d9c.htm SC14D9C 17328
2 EXHIBIT 99.1 tm2328024d1_ex99-1.htm EX-99.1 11490
  Complete submission text file 0001104659-23-107706.txt   30547
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filed by) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Subject) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-87033 | Film No.: 231315347
SIC: 2834 Pharmaceutical Preparations